Page 161 - medicina-integrativa_compress

154 PARTE II, SECCIÓN 2 NEUROLOGÍA

7. Trauninger A, Pfund Z, Koszegi T, Czopf J: Oral magnesium load 30. Lipton RB, Gobel H, Einhaupl KM, et al: Petasites hybridus root
test in patients with migraine. Headache 42:114-119, 2002. (butterbur) is an effective preventive treatment for migraine.
8. Bianchi A, Salomone S, Caraci F, et al: Role of magnesium, Neurology 63:2240-2244, 2004.
coenzyme Q 10 , riboflavin, and vitamin B 12 in migraine prophylaxis. 31. Diener HC, Rahlfs VW, Danesch U: The first placebo-controlled
Vitam Horm 69:297-312, 2004. trial of a special butterbur root extract for the prevention of
9. Wang F, Van Den Eeden SK, Ackerson LM, et al: Oral magnesium migraine: Reanalysis of efficacy criteria. Eur Neurol 51(2):89-97,
oxide prophylaxis of frequent migrainous headache in children: 2004;
A randomized, double-blind, placebo-controlled trial. Headache 32. Pothmann R, Danesch U: Migraine prevention in children and
43:601-610, 2003. adolescents: Results of an open study with a special butterbur root
10. Boska MD, Welch KM, Barker PB, et al: Contrasts in cortical extract. Headache 45:196-203, 2005.
magnesium, phospholipid, and energy metabolism between 33. Leone M, D’Amico D, Moschiano F, et al: Melatonin versus placebo
migraine syndromes. Neurology 58:1227-1233, 2002. in the prophylaxis of cluster headache: A double-blind pilot study
11. Durlach J, Pages N, Bac P, et al: Headache due to photosensitive with parallel groups. Cephalalgia 16:494-496, 1996.
magnesium depletion. Magnes Res 18:109-122, 2005. 34. Gagnier JJ: The therapeutic potential of melatonin in migraines and
12. Durlach J, Pages N, Bac P, et al: Magnesium depletion with other headache types. Altern Med Rev 6:383-389, 2001.
hypofunction or hyperfunction of the biological clock may be involved 35. Peres MF, Rozen TD: Melatonin in the preventive treatment of
in chronopathological forms of asthma. Magnes Res 18:19-34, 2005. chronic cluster headache. Cephalalgia 21:993-995, 2001.
13. Peikert A, Wilimzig C, Kohne-Volland R: Prophylaxis of migraine 36. Gutierrez S, Ang-Lee MK, Walker DJ, Zacny JP: Assessing subjective
with oral magnesium: Results from a prospective, multi-center, and psychomotor effects of the herbal medication valerian in healthy
placebo-controlled and double-blind randomized study. Cephalalgia volunteers. Pharmacol Biochem Behav 78:57-64, 2004.
16:257-263, 1996. 37. Monograph. Valeriana officinalis. Altern Med Rev 9:438-441, 2004.
14. Facchinetti F, Sances G, Borella P, et al: Magnesium prophylaxis of 38. Block KI, Gyllenhaal C, Mead MN: Safety and efficacy of herbal
menstrual migraine: Effects on intracellular magnesium. Headache sedatives in cancer care. Integr Cancer Ther 3:128-148, 2004.
31:298-301, 1991. 39. Gale C, Oakley-Browne M: Generalised anxiety disorder. Clin Evid
15. Bigal ME, Bordini CA, Tepper SJ, Speciali JG: Intravenous Jun(11):1302-1318, 2004.
magnesium sulphate in the acute treatment of migraine without 40. Barnes N, Millman G, James E: Migraine headache in children.
aura and migraine with aura: A randomized, double-blind, placebo- Clin Evid Dec(10):429-436, 2003.
controlled study. Cephalalgia 22:345-353, 2002. 41. Chronicle E, Mulleners W: Anticonvulsant drugs for migraine
16. Cete Y, Dora B, Ertan C, et al: A randomized prospective placebo- prophylaxis. Cochrane Database Syst Rev (3):CD003226, 2004.
controlled study of intravenous magnesium sulphate vs. 42. Diamond M, Cady R: Initiating and optimizing acute therapy for
metoclopramide in the management of acute migraine attacks in the migraine: The role of patient-centered stratified care. Am J Med
emergency department. Cephalalgia 25:199-204, 2005. 118(Suppl 1):18S-27S, 2005.
17. Mauskop A, Altura BT, Cracco RQ, Altura BM: Intravenous 43. Landy SH, Lobo BL: Migraine treatment throughout the lifecycle.
magnesium sulfate rapidly alleviates headaches of various types. Expert Rev Neurother 5:343-353, 2005.
Headache 36:154-160, 1996. 44. Conway S, Delplanche C, Crowder J, Rothrock J: Botox therapy for
18. Barbiroli B, Montagna P, Cortelli P, et al: Abnormal brain and refractory chronic migraine. Headache 45:355-357, 2005.
31
muscle energy metabolism shown by P magnetic resonance 45. Dodick DW, Mauskop A, Elkind AH, et al: Botulinum toxin type A
spectroscopy in patients affected by migraine with aura. Neurology for the prophylaxis of chronic daily headache—subgroup analysis of
42:1209-1214, 1992. patients not receiving other prophylactic medications: A randomized
19. Sandor PS, Afra J, Ambrosini A, Schoenen J: Prophylactic treatment double-blind, placebo-controlled study. Headache 45:315-324,
of migraine with beta-blockers and riboflavin: Differential effects on 2005.
the intensity dependence of auditory evoked cortical potentials. 46. Wheeler AH: Botulinum toxin A: Adjunctive therapy for refractory
Headache 40:30-35, 2000. headaches associated with pericranial muscle tension. Headache
20. Boehnke C, Reuter U, Flach U, et al: High-dose riboflavin treatment 38:468-471, 1998.
is efficacious in migraine prophylaxis: An open study in a tertiary 47. Rollnik JD, Tanneberger O, Schubert M, et al: Treatment of tension-
care centre. Eur J Neurol 11:475-477, 2004. type headache with botulinum toxin type A: A double-blind,
21. Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose placebo-controlled study. Headache 40:300-305, 2000.
riboflavin in migraine prophylaxis: A randomized controlled trial. 48. Walach H, Lowes T, Mussbach D, et al: The long-term effects of
Neurology 50:466-470, 1998. homeopathic treatment of chronic headaches: One-year follow-up.
22. Littarru GP, Tiano L: Clinical aspects of coenzyme Q 10 : An update. Cephalalgia 20:835-837, 2000.
Curr Opin Clin Nutr Metab Care 8:641-646, 2005. 49. Lipton RB, Cutrer FM, Goadsby PJ, et al: How treatment priorities
23. Rozen TD, Oshinsky ML, Gebeline CA, et al: Open label trial of influence triptan preferences in clinical practice: Perspectives of
coenzyme Q 10 as a migraine preventive. Cephalalgia 22:137-141, migraine sufferers, neurologists, and primary care physicians. Curr
2002. Med Res Opin 21:413-424, 2005.
24. Sandor PS, Di Clemente L, Coppola G, et al: Efficacy of coenzyme 50. Mathew NT, Loder EW: Evaluating the triptans. Am J Med
Q 10 in migraine prophylaxis: A randomized controlled trial. 118(Suppl 1):28S-35S, 2005.
Neurology 64:713-715, 2005. 51. Moschiano F, D’Amico D, Allais G, et al: Early triptan intervention
25. Harel Z, Gascon G, Riggs S, et al: Supplementation with omega-3 in migraine: An overview. Neurol Sci 26(Suppl 2):S108-S110,
polyunsaturated fatty acids in the management of recurrent 2005.
migraines in adolescents. J Adolesc Health 31:154-161, 2002. 52. Mullins CD, Weis KA, Perfetto EM, et al: Triptans for migraine
26. Pradalier A, Bakouche P, Baudesson G, et al: Failure of omega-3 therapy: A comparison based on number needed to treat and doses
polyunsaturated fatty acids in prevention of migraine: A double-blind needed to treat. J Manag Care Pharm 11:394-402, 2005.
study versus placebo. Cephalalgia 21:818-822, 2001. 53. Taylor FR: Migraine headache: Options for acute treatment. Curr
27. Johnson ES, Kadam NP, Hylands DM, Hylands PJ: Efficacy of Neurol Neurosci Rep 5:86-92, 2005.
feverfew as prophylactic treatment of migraine. BMJ 291:569-573, 54. Marcus DA, Scharff L, Mercer S, Turk DC: Nonpharmacological
1985. treatment for migraine: Incremental utility of physical therapy with
28. Murphy JJ, Heptinstall S, Mitchell JR: Randomised double-blind relaxation and thermal biofeedback. Cephalalgia 18:266-272,
placebo-controlled trial of feverfew in migraine prevention. Lancet discussion 242, 1998.
2:189-192, 1988. 55. Holroyd KA, Penzien DB: Pharmacological versus non-
29. Pfaffenrath V, Diener HC, Fischer M, et al: The efficacy and safety pharmacological prophylaxis of recurrent migraine headache:
of Tanacetum parthenium (feverfew) in migraine prophylaxis: A meta-analytic review of clinical trials. Pain 42:1-13, 1990.
A double-blind, multicentre, randomized placebo-controlled 56. Campbell JK: Manifestations of migraine. Neurol Clin 8:841-855,
dose-response study. Cephalalgia 22:523-532, 2002. 1990.
29a. Maizels M, Blumenfeld A, Burchette R: A combination of riboflavin, 57. Bogaards MC, ter Kuile MM: Treatment of recurrent tension
magnesium, and feverfew for migraine prophylaxis: A randomized headache: A meta-analytic review. Clin J Pain 10:174-190,
trial. Headache 44:885-890, 2004. 1994.